Evidence map›Paper›PMID 31548706›Full record

ArticleNature methods2019

Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging.

Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, Theodosia Vallianatou, Patrik Källback, Luay Katan, Jonas Sävmarker, Ioannis Mantas, Xiaoqun Zhang, Erwan Bezard and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Spatiotemporal Dynamics of Polyphenolic Compounds inJournal of agricultural and food chemistry · 2026
    Article
  17. Article
  18. ExploringFrontiers in cell and developmental biology · 2026
    Article
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mohammadreza ShariatgorjiMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Anna NilssonMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Elva FridjonsdottirMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-3779-3556
Theodosia VallianatouMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Patrik KällbackMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Luay KatanDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Jonas SävmarkerDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Ioannis MantasSection of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Xiaoqun ZhangSection of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Erwan BezardInstitut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0002-0410-4638
Per SvenningssonSection of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Luke R OdellDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. luke.odell@ilk.uu.se.ORCID http://orcid.org/0000-0001-7658-5103
Per E AndrénMedical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. per.andren@farmbio.uu.se.ORCID http://orcid.org/0000-0002-4062-7743

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a mass spectrometry imaging (MSI) approach for the comprehensive mapping of neurotransmitter networks in specific brain regions. Our fluoromethylpyridinium-based reactive matrices facilitate the covalent charge-tagging of molecules containing phenolic hydroxyl and/or primary or secondary amine groups, including dopaminergic and serotonergic neurotransmitters and their associated metabolites. These matrices improved the matrix-assisted laser desorption/ionization (MALDI)-MSI detection limit toward low-abundance neurotransmitters and facilitated the simultaneous imaging of neurotransmitters in fine structures of the brain at a lateral resolution of 10 µm. We demonstrate strategies for the identification of unknown molecular species using the innate chemoselectivity of the reactive matrices and the unique isotopic pattern of a brominated reactive matrix. We illustrate the capabilities of the developed method on Parkinsonian brain samples from human post-mortem tissue and animal models. The direct imaging of neurotransmitter systems provides a method for exploring how various neurological diseases affect specific brain regions through neurotransmitter modulation.

Indexed as

AnimalsBrainDisease Models, AnimalHumansLimit of DetectionNeurotransmitter AgentsParkinson DiseasePrimatesRatsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationNeurotransmitter Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.